Reviva Pharmaceuticals: Q1 Earnings Insights


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Reviva Pharmaceuticals (NASDAQ:RVPH) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings

Reviva Pharmaceuticals missed estimated earnings by 42.86%, reporting an EPS of $-0.4 versus an estimate of $-0.28.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 4.65% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Reviva Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: EarningsBZI-Recaps